A detailed history of Shaker Investments LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Shaker Investments LLC holds 10,572 shares of CPRX stock, worth $256,899. This represents 0.13% of its overall portfolio holdings.

Number of Shares
10,572
Holding current value
$256,899
% of portfolio
0.13%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025

BUY
$19.53 - $25.74 $206,471 - $272,123
10,572 New
10,572 $256,000

Others Institutions Holding CPRX

About CATALYST PHARMACEUTICALS, INC.


  • Ticker CPRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 102,820,000
  • Market Cap $2.5B
  • Description
  • Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...
More about CPRX
Track This Portfolio

Track Shaker Investments LLC Portfolio

Follow Shaker Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Shaker Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shaker Investments LLC with notifications on news.